Francesca Spence-Jackson
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 20, 2026
VEGF-TKI Outcomes in Metastatic Renal Cell Carcinoma According to Prior Immune Checkpoint Inhibitor or VEGF-TKI: A Scoping Review and Exploratory Analysis.
Journal: Cancers
Published: December 30, 2025
Three versus six cycles of platinum-based chemotherapy followed by avelumab maintenance as first-line treatment for advanced urothelial cancer: the phase II DISCUS trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 25, 2025
Established and emerging biomarkers approaches in urothelial carcinoma.
Journal: Expert review of anticancer therapy
Published: August 05, 2025
Is HER2 the New NECTIN4 in Advanced Urothelial Cancer?
Journal: European urology focus
Published: March 26, 2024
NLR Outperforms Low Hemoglobin and High Platelet Count as Predictive and Prognostic Biomarker in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Journal: Clinical genitourinary cancer
Published: December 06, 2023
Upper Tract Urothelial Carcinoma (UTUC): Prevalence, Impact and Management Challenge.
Journal: Cancer management and research
Published: October 19, 2023
Systemic therapies and primary tumour downsizing in renal cell carcinoma: a real-world comparison of anti-angiogenic and immune checkpoint inhibition regimens.
Journal: World journal of urology
Published: August 21, 2023
Last Updated: 09/26/2026